Treatment of experimentally induced Pasteurella multocida infections in broilers and turkeys: Comparative studies of different oral treatment regimens

Journal of Veterinary Medicine, Series B

Volumn 49, Issue 3, 2002, Pages 130-134

  Sarkozy G ^a   Semjen G ^a   Laczay, P ^a   Horvath E ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b State Control Institute for Veterinary Biologicals   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG ADMINISTRATION; DRUG THERAPY; NORFLOXACIN; PHARMACOLOGY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; DRUG THERAPY; FEMALE; GRAM NEGATIVE INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION; PASTEURELLA MULTOCIDA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TURKEY (BIRD);

ADMINISTRATION AND DOSAGE; ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; CHICKENS; DRUG ADMINISTRATION SCHEDULE; DRUG EFFECTS; DRUG THERAPY; FEMALE; MALE; MICROBIAL SENSITIVITY TESTS; NORFLOXACIN; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PHARMACOLOGY; POULTRY DISEASES; THERAPEUTIC USE; TREATMENT OUTCOME; TURKEYS; VETERINARY;

AVES; GALLIFORMES; GALLUS GALLUS; MELEAGRIS GALLOPAVO; NEGIBACTERIA; PASTEURELLA; PASTEURELLA MULTOCIDA;

EID: 0036236035     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0450.2002.00518.x     Document Type: Article

References (15)

1. Discovery and development of new antimicrobial agents
2. Pasteurella multocida as a cause of disease outbreaks in commercial poultry flocks
3. Fowl cholera - The old enemy returns
4. Comparative studies on the pharmacokinetics of norfloxacin in chickens, turkeys and geese after a single oral administration
5. Efficacy of norfloxacin nicotinate treatment of broiler breeders against Haemophilus paragallinarum
6. Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect using three strains of Pseudomonas aeruginosa and in vitro pharmacodynamic model
7. Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections
8. The post-antimicrobial suppressive effect of quinolone agents
9. In vitro susceptibility of avian Escherichia coli and Pasteurella multocida to danofloxacin and five other antimicrobials
10. Pasteurellosis
11. Fowl cholera
12. Pharmacodynamics of the fluoroquinolones
13. In vitro characterization of field isolates of Pasteurella multocida from Georgia turkeys
14. Norfloxacin - A review of pharmacology and tissue penetration
15. Norfloxacin: A new targeted fluoroquinolone antimicrobial agent